Dthera Sciences
7310 Miramar Road
San Diego
California
92126
United States
Tel: 858-215-6360
Website: http://dthera.com
Email: Team@dthera.com
About Dthera Sciences
Dthera Sciences is a publicly-traded San Diego-based company working to create an innovative Digital Therapeutic to improve the Quality of Life and reduce anxiety in patients with Alzheimer's and Dementia. The Company was formed through the merger of Knowledge Machine International and EveryStory, Inc. and the acquisition of the SeniorsInTouch intellectual property portfolio. The Company's lead product, EveryStory, is a digital story-telling platform that is powered by propriety artificial intelligence technology and specifically targeting the Senior Living market. The EveryStory product is presently entering a clinical trial with a major public university to test its effectiveness as Reminiscence Therapy.YEAR FOUNDED:
2013
LEADERSHIP:
CEO: Edward Cox
CTO: Dave Keene
FOLLOW DTHERA:
Tweets by Dthera
8 articles about Dthera Sciences
-
Kansas City Based Health Care Startup Buys Digital Therapeutics Company Focused on Alzheimer's and Dementia
5/11/2022
Telememory Holding Corp., the makers of MoodSpark, has purchased Dthera Sciences, a pioneer in the digital therapeutics industry and leader in developing innovative quality of life therapies for those suffering from cognitive decline.
-
Dthera Sciences Receives FDA Breakthrough Device Designation For Its Alzheimer's Focused Development-Stage Product "DTHR-ALZ"
8/23/2018
Dthera™ Sciences announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
-
DTxDM - the Home of Validated Digital Healthcare, Announces Its Founding Partners at the Launch of the New Hub for Everyone Working in Digital Therapeutics and Digital Medicine
6/13/2018
DTxDM are delighted to announce that Sanofi, Dthera Sciences and Cognoa have joined as founding partners at the launch of the new DTxDM Hub.
-
Dthera Sciences Announces 2017 Financial Results and Provides Business Update
4/3/2018
Lead Product, ReminX™, a First of its Kind Digital Reminiscence Therapy Platform to Launch in Q2
-
Digital Therapeutic Leaders Dthera Sciences' and Click Therapeutics' CEOs to act as Co-Chairs of First Ever Digital Therapeutics and Digital Medicine Summit
2/27/2018
Dthera Sciences (OTCQB:DTHR), a digital therapeutics company focused on developing innovative digital quality of life therapies for neurodegenerative diseases, is pleased to announce its CEO, Edward Cox, has been selected to co-chair the Digital Therapeutics and Digital Medicine Summit (DTxDM) alongside David Benshoof Klein, CEO of Click Therapeutics, a company developing software as prescription medical treatments.
-
CurePSP & Dthera Sciences Announce Initial Positive Results Of Pilot Program
10/4/2017
-
Dthera Sciences Approved For Trading On OTCQB Venture Market; Provides Corporate Update
9/21/2017
-
Dthera Sciences Announces Results Of Clinical Study Of Its Product ReminX
4/10/2017